Overview

Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model

Status:
Unknown status

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

This is a single center, single arm, open and exploratory clinical study, with 50 cases planned for a period of 2 years. The purpose of this study is to evaluate the consistency and accuracy of Patient-Derived Organoid Model of breast cancer to predict the clinical efficacy of the drug, as well as the possibility of guiding the neoadjuvant chemotherapy.

Phase:

N/A

Details

Lead Sponsor:

Peking Union Medical College

Treatments:

Albumin-Bound Paclitaxel
Paclitaxel